Nanomedicine and nutraceutical-based nanocarriers for specific delivery to cancer stem cells: targeted drug delivery at the STEM frontier [0.03%]
针对癌症干细胞的特异性递送的纳米医学及保健食品基纳米载体：STEM领域的药物递送新前沿
Enas Daoud,Waleed K Abdulsahib,Sajida Hussein Ismael et al.
Enas Daoud et al.
Advancing liver cancer diagnosis and treatment with multi-omics approaches: a systematic review [0.03%]
多组学方法在肝癌诊断和治疗中的应用进展：系统综述
Esraa M Hashem,Ayat M Karrar,Mai S Mabrouk
Esraa M Hashem
Hepatocellular carcinoma (HCC), the most prevalent form of liver cancer, remains a major global health concern due to challenges in early detection and limited treatment options. Multi-omics technologies-such as genomics, proteomics, and me...
Keratin 80 serves as a potential biomarker in metastatic breast cancer [0.03%]
波状角蛋白80可作为乳腺癌转移的生物标志物
Feng Sun,Dan Wang,Mengmeng Chen et al.
Feng Sun et al.
Background: Breast cancer (BC) is the most common type of female cancer with alarmingly high morbidity and mortality, especially metastatic BC (mBC). Obje...
Chemotherapy and age stratified survival outcomes in colorectal cancer based on a population analysis from the surveillance epidemiology and end results program 2010 to 2020 [0.03%]
基于SEER项目(2010-2020)人群数据分析结直肠癌化疗的分层年龄生存结局
Guoshuai Xu,Wenqiang Li,Nan Yao et al.
Guoshuai Xu et al.
Background: The role of chemotherapy in colorectal cancer (CRC) treatment, particularly in elderly and very young patients, remains controversial. This study aims to evaluate the survival benefits of chemotherapy across d...
Artificial intelligence in head and neck cancer: a bibliometric and visualization analysis (1995-2025) [0.03%]
头颈部肿瘤领域的人工智能：1995-2025年的文献计量和可视化分析
Chuyi Cai,Jingfeng Zhang,Chunshu Pan et al.
Chuyi Cai et al.
Objectives: Head and neck cancers (HNCs) pose significant challenges for clinical diagnosis and treatment due to their complex anatomical structures, atypical early symptoms, and the considerable morbidities associated wi...
Jing Chen,Shan Zhang,Yi Zhao et al.
Jing Chen et al.
Epstein-Barr virus (EBV) remains dormant in host B cells for a long time, and more than 90% of patients are asymptomatically infected. However, some internal factors (such as immune deficiency) or exogenous factors (such as HIV infection, i...
Bibliometric evaluation of research trends and hotspots concerning the interaction between immune checkpoint inhibitors and glioma [0.03%]
免疫检查点抑制剂与胶质瘤相互作用的研究趋势和热点的 bibliometrix 评价
Dingwen Xu,Liang He,Xu Zhao et al.
Dingwen Xu et al.
Introduction: Immune checkpoint inhibitors have revolutionized oncology, but their efficacy in glioma remains a major focus of research. This study employs bibliometric methods to analyze the current research status and e...
Prognostic and microenvironmental analysis of pancreatic cancer by tumor location [0.03%]
基于肿瘤位置的胰腺癌预后和微环境分析
Zedian Chen,Zichang Dai,Shaomei Lin
Zedian Chen
Background: Pancreatic cancer exhibits distinct biological and clinical features according to tumor location. Differences in survival and molecular programs among head (PH), body (PB), and tail (PT) tumors remain unclear....
Cancer immunotherapy by adenosinergic CD39 and CD73 as emerging immune checkpoints [0.03%]
腺苷受体CD39和CD73作为新兴免疫检查点的癌症免疫治疗
Xinyu Yin,Ying Yang,Songjiang Liu
Xinyu Yin
Extracellular adenosine has recently been identified as an immunological checkpoint mediator that hinders the immune response to malignancies. The production of adenosine is facilitated by the enzymatic activity of CD39 and CD73. There is a...
PDK4 as a tumor suppressor in gastric cancer: implications for metabolic regulation, immune modulation, and prognostic potential [0.03%]
PDK4在胃癌中的抑癌作用：代谢调节、免疫调控及预后价值的启示
Jin Xu,Jie Sun,Nannan Zhang et al.
Jin Xu et al.
Objective: Gastric cancer (GC) remains a leading cause of cancer-related mortality, with growing evidence implicating metabolic regulators in its progression. This study investigates the expression pattern, prognostic sig...